Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
SCENARIOS-Stroke study data to be watershed for Bayer stock
Reuters: Company News
Posted on October 15, 2010 at 08:24 AM EDT
FRANKFURT, Oct 15 (Reuters) - Study results due shortly on its Xarelto anti-blood-clotting drug will determine whether Bayer gets a crack at a $12 billion plus market and will mark a turning point for its stock price.
Read More >>
Bay National Corporation
Bristol-Myers Squibb Co.
Johnson & Johnson
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here